Sandoz Group AG (XSWX:SDZ) Other Stockholders Equity: CHF7,459 Mil (As of Dec. 2025)


XSWX:SDZ Sandoz Group AG XSWX:SDZ
11 GF Score
Price CHF67.78
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Other Stockholders Equity?

Sandoz Group AG XSWX:SDZ -1.20% 11 Other Stockholders Equity is CHF7,459 Mil as of Dec. 2025. GuruFocus rates XSWX:SDZ with a GF Score™ of 11/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's Other Stockholders Equity for the quarter that ended in Dec. 2025 was CHF7,459 Mil.

Sandoz Group AG's quarterly Other Stockholders Equity declined from Dec. 2024 (CHF7,257 Mil) to Jun. 2025 (CHF7,152 Mil) but then increased from Jun. 2025 (CHF7,152 Mil) to Dec. 2025 (CHF7,459 Mil).

Sandoz Group AG's annual Other Stockholders Equity declined from Dec. 2023 (CHF7,455 Mil) to Dec. 2024 (CHF7,257 Mil) but then increased from Dec. 2024 (CHF7,257 Mil) to Dec. 2025 (CHF7,459 Mil).

Sandoz Group AG Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Other Stockholders Equity Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
0.00 7,455.44 7,256.73 7,458.98

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial 7,455.44 7,456.97 7,256.73 7,152.09 7,458.98
XSWX:SDZ
11GF Score
Sandoz Group AG XSWX:SDZ
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of CHF7,459 Mil mean?
Sandoz Group AG (XSWX:SDZ) has a Other Stockholders Equity of CHF7,459 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Other Stockholders Equity too high?
Sandoz Group AG's current Other Stockholders Equity is CHF7,459 Mil. Overall, Sandoz Group AG has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Other Stockholders Equity compare to ZTS and UTHR?
Sandoz Group AG's Other Stockholders Equity of CHF7,459 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Other Stockholders Equity is CHF7,459 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (XSWX:SDZ) has a current Other Stockholders Equity of CHF7,459 Mil. The current Other Stockholders Equity is CHF7,459 Mil. Sandoz Group AG's overall GF Score™ is 11/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sandoz Group AG (XSWX:SDZ), the current Other Stockholders Equity is CHF7,459 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
11GF Score

Get the complete analysis for XSWX:SDZ

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF67.78
Price